Literature DB >> 33194025

Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Yehui Zhou1,2, Xiaorong Liu1,3, Jing Lan2, Yuqiu Wan2, Xun Zhu1.   

Abstract

Circular RNAs (circRNAs), which are considered to be important functional regulators in cancer, have provided a new perspective regarding our understanding of tumor biology, including that of breast cancer. To investigate the regulatory effect of circRPPH1 on cellular behaviors of breast cancer and the potential mechanism, the expression of circRPPH1 and miR-556-5p in breast cancer tissues and cell lines were examined by quantitative RT-PCR. The regulatory effects of the circRPPH1/miR-556-5p/YAP1 axis on cellular behaviors of breast cancer cells were evaluated through functional experiments in vitro and tumor growth in vivo. The relationship between circRPPH1 and miR-556-5p/YAP1 was assessed using dual-luciferase reporter and RNA immunoprecipitation assays. PCR results showed that circRPPH1 levels were significantly upregulated in tumor tissues and breast cancer cells. Functionally, circRPPH1 promoted the proliferation, migration, invasion, and angiogenesis of breast cancer cell lines and tumor growth in vivo. Regarding the mechanism, dual-luciferase reporter and RNA immunoprecipitation assays showed that circRPPH1 was capable of sponging miR-556-5p to increase expression of the oncogene YAP1. Our data reveal that circRPPH1 plays a vital regulatory role in breast cancer via the miR-556-5p/YAP1 axis and may serve as a promising therapeutic target for breast cancer treatment. AJTR
Copyright © 2020.

Entities:  

Keywords:  Breast cancer; YAP1; circRPPH1; miR-556-5p; miRNA sponge

Year:  2020        PMID: 33194025      PMCID: PMC7653573     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  36 in total

Review 1.  Circular RNA and miR-7 in cancer.

Authors:  Thomas B Hansen; Jørgen Kjems; Christian K Damgaard
Journal:  Cancer Res       Date:  2013-09-06       Impact factor: 12.701

2.  Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.

Authors:  Michael Overholtzer; Jianmin Zhang; Gromoslaw A Smolen; Beth Muir; Wenmei Li; Dennis C Sgroi; Chu-Xia Deng; Joan S Brugge; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

Review 3.  Circular RNAs: analysis, expression and potential functions.

Authors:  Steven P Barrett; Julia Salzman
Journal:  Development       Date:  2016-06-01       Impact factor: 6.868

4.  Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer.

Authors:  Xiaodan Wang; Lili Su; Qishui Ou
Journal:  Eur J Cancer       Date:  2011-11-05       Impact factor: 9.162

5.  Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer.

Authors:  Jie Chen; Yan Li; Qiupeng Zheng; Chunyang Bao; Jian He; Bin Chen; Dongbin Lyu; Biqiang Zheng; Yu Xu; Ziwen Long; Ye Zhou; Huiyan Zhu; Yanong Wang; Xianghuo He; Yingqiang Shi; Shenglin Huang
Journal:  Cancer Lett       Date:  2016-12-13       Impact factor: 8.679

6.  CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.

Authors:  Jie Wu; Zerun Jiang; Chen Chen; Qingsong Hu; Ziyi Fu; Junjie Chen; Zhangding Wang; Qiang Wang; Aiping Li; Jeffrey R Marks; Changying Guo; Yun Chen; Jianwei Zhou; Liuqing Yang; Chunru Lin; Shouyu Wang
Journal:  Cancer Lett       Date:  2018-05-25       Impact factor: 8.679

7.  Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.

Authors:  Rozina Tufail; Mercy Jorda; Wei Zhao; Isildinha Reis; Zafar Nawaz
Journal:  Breast Cancer Res Treat       Date:  2011-03-12       Impact factor: 4.872

8.  Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.

Authors:  Ying Chen; Zetian Shen; Yingru Zhi; Hao Zhou; Kai Zhang; Ting Wang; Bing Feng; Yitian Chen; Haizhu Song; Rui Wang; Xiaoyuan Chu
Journal:  Arch Biochem Biophys       Date:  2018-03-17       Impact factor: 4.013

9.  circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.

Authors:  Rongfang He; Peng Liu; Xiaoming Xie; Yujuan Zhou; Qianjin Liao; Wei Xiong; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng; Hailin Tang
Journal:  J Exp Clin Cancer Res       Date:  2017-10-16

Review 10.  Circular RNAs: Promising Biomarkers for Human Diseases.

Authors:  Zhongrong Zhang; Tingting Yang; Junjie Xiao
Journal:  EBioMedicine       Date:  2018-08-02       Impact factor: 8.143

View more
  12 in total

1.  MiR-556-5p modulates migration, invasion, and epithelial-mesenchymal transition in breast cancer cells via targeting PTHrP.

Authors:  Rongjun Zhou; Zhen Luo; Guanqun Yin; Lanting Yu; Hao Zhong
Journal:  J Mol Histol       Date:  2022-01-09       Impact factor: 2.611

2.  CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

3.  Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.

Authors:  Guoli Shao; Xulong Fan; Pusheng Zhang; Xuewen Liu; Lei Huang; Shufeng Ji
Journal:  Cell Biol Toxicol       Date:  2022-07-23       Impact factor: 6.819

4.  Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling.

Authors:  Ziang Yang; Bei Xu; Sheng Wu; Weige Yang; Rongkui Luo; Shengkai Geng; Zhaochen Xin; Wen Jin; Xiong Shen; Xixi Gu; Hongwei Zhang; Hong Wang
Journal:  Hum Cell       Date:  2022-08-09       Impact factor: 4.374

Review 5.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

Review 6.  Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.

Authors:  Zahra Foruzandeh; Davood Ghavi Dorabadi; Farzaneh Sadeghi; Fatemeh Zeinali-Sehrig; Mohammad Zaefizadeh; Yazdan Rahmati; Mohammad Reza Alivand
Journal:  Mol Biol Rep       Date:  2022-05-10       Impact factor: 2.742

Review 7.  An update on the roles of circular RNAs in spinal cord injury.

Authors:  Xuezhen Ma; Xuesong Wang; Xuexiao Ma; Xiugong Zhang; Xiaojin Gong; Ruifu Sun; Sunny H Wong; Matthew T V Chan; William Ka Kei Wu
Journal:  Mol Neurobiol       Date:  2022-02-03       Impact factor: 5.590

Review 8.  Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.

Authors:  Lijuan Lyu; Shizhen Zhang; Yujiao Deng; Meng Wang; Xinyue Deng; Si Yang; Ying Wu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2021-03-06       Impact factor: 17.388

9.  MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL.

Authors:  Gehao Liang; Yun Ling; Qun Lin; Yu Shi; Qing Luo; Yinghuan Cen; Maryam Mehrpour; Ahmed Hamai; Jun Li; Chang Gong
Journal:  Front Cell Dev Biol       Date:  2021-07-29

10.  Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death.

Authors:  Feng Shi; Luquan Zhang; Xing Liu; Yue Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.